Turn Therapeutics Inc.

NASDAQ: TTRX · Healthcare · Biotechnology

PublicHQ Westlake Village, CA · Los AngelesCIK 0002023016Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 49DQ —GM —SS 26

v0.1 · 35/100 weight · pillars only

↑ Altman-Z, market scale · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$3.2M

Employees

as of 2026-08-18

Market cap

$249.0M

as of 2026-08-18

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$3.2M-$3.2M2025

Operating income-$5.9M-$5.9M2025

Total assets$12.2M$12.2M2025

Liabilities$7.5M$7.5M2025

Equity$4.7M$4.7M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Turn Therapeutics Inc.’s financial profile?

Turn Therapeutics Inc. earned -$3.2M in FY2025 net income.

Peers · Healthcare

Scribe Therapeutics Inc.——Neumora Therapeutics, Inc. Common Stock——Anavex Life Sciences Corp.——Alamar Biosciences, Inc.——Aurora Cannabis Inc.——Greenwich LifeSciences, Inc.——

Neighbors

Los Angeles →

The Walt Disney Company$94.4B72B Public Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68B Live Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D

Key facts

CEOBradley E. Burnam

SectorHealthcare

IndustryBiotechnology

HeadquartersWestlake Village, CA

ExchangeNASDAQ: TTRX

Employees2

IPO date2025-10-08

Latest filings

8-K2026-08-18 8-K2026-08-17 8-K2026-08-12 10-Q2026-08-12 8-K2026-07-28 8-K2026-07-07 8-K2026-06-03 8-K2026-06-01

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.